<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371486</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-14-1399-RM-CTIL</org_study_id>
    <nct_id>NCT02371486</nct_id>
  </id_info>
  <brief_title>Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?</brief_title>
  <official_title>Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cesarean scar defects (CSDs), i.e. deficient uterine scars following a cesarean section,
      involve discontinuity at the site of a previous Cesarean section scar. These anatomical
      defects have been reported to be associated with postmenstrual spotting, chronic pelvic pain
      and infertility. Few case series have suggested improved fertility (most probably by
      improving implantation of embryos) The aim of this study is to prospectively record embryonal
      implantation rate during IVF in patients with CSDs, and to evaluate the effect of
      hysteroscopic repair of CSDs on fetal implantation during IVF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      150 patients undergoing IVF after cesarean section will be recruited. demographic, clinical
      and treatment data will be collected. ultrasound and hysteroscopic evaluation of the CSD will
      be performed. IVF treatment will be provided. In case of failure of IVF treatment, patients
      will be randomized to hysteroscopic repair of CSD versus second IVF treatment
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Embryo implantation rate</measure>
    <time_frame>completion of two IVF cycles after randomization - approx. 2 months</time_frame>
    <description>Embryo implantation rate during IVF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluid in Uterus</measure>
    <time_frame>completion of two IVF cycles after randomization - approx. 2 months</time_frame>
    <description>Detection of fluid in the uterine cavity during menotropin stimulation in IVF treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between size and type of the defect fluid accumulation</measure>
    <time_frame>completion of two IVF cycles after randomization - approx. 2 months</time_frame>
    <description>Correlation between the size and type of the defect and the detection of fluid in the uterine cavity during menotropin stimulation in IVF treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between the size and type of the defect and implantation rate during IVF treatment</measure>
    <time_frame>completion of two IVF cycles after randomization - approx. 2 months</time_frame>
    <description>Correlation between the size and type of the defect and implantation rate during IVF treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infertility</condition>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Nich Repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventions to be administered:
Ultrasound Scan
Diagnostic Hysteroscopy
hysteroscopic repair of cesarean section defect
IVF cycle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Repair</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Interventions to be administered:
Ultrasound Scan
Diagnostic Hysteroscopy
IVF cycle Operative hysteroscopy WILL NOT BE PERFORMED</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hysteroscopic repair of cesarean section defect</intervention_name>
    <description>Operative hysteroscopy for the repair of cesarean section defect is performed under general anesthesia. the cervix is dilated and the cesarean section defect opened. polypoid tissue is ablated</description>
    <arm_group_label>Nich Repair</arm_group_label>
    <other_name>hysteroscopic metroplasty, niche repair</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Diagnostic Hysteroscopy</intervention_name>
    <description>Betthochi's method for diagnostic hysteroscopy: No anesthesia will be used. vaginoscopy will be performed, followed by diagnostic hysteroscopy. saline will be used as a distension media. 4.2 mm Storz hysteroscope will be used.</description>
    <arm_group_label>Nich Repair</arm_group_label>
    <arm_group_label>No Repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound Scan</intervention_name>
    <description>Scanning the uterus with the ultrasound probe . Transvaginal ultrasound usually produces better and clearer images of the female pelvic organs, because the ultrasound probe lies closer to these structures.
The transvaginal ultrasound probe is thin, about 2cm diameter. The probe is covered with a disposable protective sheath. A small amount of ultrasound gel is placed on the end of this probe. The probe is then gently inserted a short distance into the vagina.</description>
    <arm_group_label>Nich Repair</arm_group_label>
    <arm_group_label>No Repair</arm_group_label>
    <other_name>Internal ultrasound</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVF Cycle</intervention_name>
    <description>Controlled ovarian hyperstimulation, followed by Human chorionic Gonadotropin ( hCG) administration, Ovum Pickup and Embryo transfer</description>
    <arm_group_label>Nich Repair</arm_group_label>
    <arm_group_label>No Repair</arm_group_label>
    <other_name>IVF Treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing IVF after cesarean section

        Exclusion Criteria:

          -  Patients who underwent CSD repair

          -  Patients with low ovarian reserve

          -  Patients with hydrosalpinges, endometriosis, adenomyosis, submucous fibroids or polyps
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lilia Margolis-Dorfman, M.P.H</last_name>
    <phone>+972-3530-4948</phone>
    <email>lilia.mdorfman@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roy Mashiach, M.D</last_name>
    <phone>+972-35302773</phone>
    <email>Roy.mashiach@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The chaim sheba medical center,Tel Hashomer</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52503</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Mashiach, MD</last_name>
      <phone>+97236130077</phone>
      <email>roy.mashiach@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>October 12, 2016</last_update_submitted>
  <last_update_submitted_qc>October 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Roy Mashiach, M.D.</investigator_full_name>
    <investigator_title>Vice Chairman Gynecological Department</investigator_title>
  </responsible_party>
  <keyword>cesarean section defect</keyword>
  <keyword>implantation</keyword>
  <keyword>ivf</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

